BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 31012139)

  • 21. POEMS syndrome with undetectable M-protein: a case report and literature review.
    Xue HY; Zhou L; Yuan QZ; Zhang Y; Hao YQ; Chen SW; Wang HK; Wei F
    Diagn Pathol; 2024 Jun; 19(1):74. PubMed ID: 38849857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
    Khouri J; Nakashima M; Wong S
    JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes syndrome without polyneuropathy: A case report.
    Li Q; Xu F; Duan JF; Tang YF
    Medicine (Baltimore); 2020 Jul; 99(27):e20812. PubMed ID: 32629667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proposal of new clinical diagnostic criteria for POEMS syndrome.
    Suichi T; Misawa S; Sato Y; Beppu M; Sakaida E; Sekiguchi Y; Shibuya K; Watanabe K; Amino H; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):133-137. PubMed ID: 30279213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic analysis of POEMS syndrome and related diseases.
    Shi X; Hu S; Yu X; Zhuang Q; Luo M; Jiang Q; Wang L; Lu Y; Fei X; Xi X; Zhu Y
    Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):e15-21. PubMed ID: 25131854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombosis revealing POEMS syndrome. About a case.
    Dumas C; Bienvenu FH; Hicks J; Weber E; Sève P
    Ann Biol Clin (Paris); 2020 Apr; 78(2):195-197. PubMed ID: 32162605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
    He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
    Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment options for POEMS syndrome.
    Dispenzieri A; Gertz MA
    Expert Opin Pharmacother; 2005 Jun; 6(6):945-53. PubMed ID: 15952922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
    Misawa S
    Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Castleman disease of the hyaline vascular variant transforming to POEMS syndrome as endpoint: a case report.
    Ge Y; Da Q; Dai Y
    BMC Neurol; 2018 Oct; 18(1):169. PubMed ID: 30301456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New strategy of treatment for POEMS syndrome--autologous peripheral blood stem cell transplantation and thalidomide therapy].
    Kuwabara S
    Brain Nerve; 2008 Jun; 60(6):627-33. PubMed ID: 18567358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [POEMS syndrome: a review of the literature].
    Méndez-Herrera CR; Cordoví-Rodríguez D
    Rev Neurol; 2011 Jul; 53(1):44-50. PubMed ID: 21678324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on the diagnosis and management of the polyneuropathy of POEMS syndrome.
    Cerri F; Falzone YM; Riva N; Quattrini A
    J Neurol; 2019 Jan; 266(1):258-267. PubMed ID: 30264176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome.
    Kuwabara S; Dispenzieri A; Arimura K; Misawa S; Nakaseko C
    Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD006828. PubMed ID: 22696361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. POEMS syndrome: diagnostic delay and successful treatment with lenalidomide, cyclophosphamide and prednisone followed by autologous peripheral stem cell transplantation.
    Ordway S; Gilbert L; Wanko S
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30054320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
    Kamezaki K; Nagafuji K
    Nihon Rinsho; 2007 Dec; 65(12):2235-7. PubMed ID: 18069266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New treatment strategy for Crow-Fukase (POEMS) syndrome].
    Kuwabara S
    Rinsho Shinkeigaku; 2010 Nov; 50(11):794-6. PubMed ID: 21921444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pituitary macroadenoma in a patient with POEMS syndrome in conjunction with Castleman disease: first report of a case and review of related literature.
    Bruno C; Fleck JD; Cavaghan MK
    Endocr Pract; 2010; 16(1):97-101. PubMed ID: 19546057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Advances in the Treatment and Supportive Care of POEMS Syndrome.
    Bou Zerdan M; George TI; Bunting ST; Chaulagain CP
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Crow-Fukase (POEMS) syndrome: pathophysiology and treatments].
    Kuwabara S
    Nihon Rinsho; 2013 May; 71(5):865-9. PubMed ID: 23777096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.